Ritonavir Tablets IP

Ritonavir Tablets IP Specification

Origin of Medicine
India

Indication
Indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection

Brand Name
Ritonavir Tablets IP

Life Span
36 months from manufacturing date

Packaging Type
Bottle

Salt Composition
Ritonavir IP

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
30 tablets per bottle

Drug Type
Allopathic

Ingredients
Ritonavir

Physical Form
Tablets

Function
Antiviral medication (Protease inhibitor)

Recommended For
Adults and children as prescribed for HIV infection management

Dosage
As directed by physician

Dosage Guidelines
Follow physicians prescription

Storage Instructions
Store below 30C, protect from moisture

Country of Export
India

MRP
As printed on packaging

Marketed By
As per packaging

Tablet Strength
100 mg

Colour
White to off-white

Bar Code
Available as per packaging

Box Dimensions
As per packaging

Shelf Condition
Keep container tightly closed

Legal Category
Schedule H (Prescription drug)

Prescription Required
Yes

Shape
Oval film-coated tablets

Warning
For use only under medical supervision

NDC/HSN Code
As per packaging

Batch Number
Present on bottle and box

Administration Route
Oral

Ritonavir Tablets IP Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About Ritonavir Tablets IP

Strength	100 mg
Packaging Size	60 Tablets
Brand Name	Ritomune
Usage/Application	Hospital, Clinic
Packaging Type	Bottle
Type Of Medicines	Allopathic
Form	Tablets
Manufactured By	Cipla

Ritomune Ritonavir IP 100Mg Tablets Product Information

Ritonavir (Generic Norvir tablets ) is an HIV protease inhibitor which is used in combination with other antiretroviral medicines for the treatment of HIV-1 infection.

Role in HIV-1 Management

Ritonavir Tablets IP are commonly prescribed alongside other antiretroviral agents for managing HIV-1 infection in adults and children above two years of age. As a protease inhibitor, ritonavir helps suppress viral replication, improving the overall effectiveness of HIV treatment and reducing the risk of complications associated with the infection.

Prescription and Administration

This medication is strictly prescription-based (Schedule H) and should only be used under the guidance of a healthcare professional. Ritonavir tablets are administered orally, and the dosing regimen is based on the patient's age, weight, and overall treatment plan as determined by a physician. Proper adherence to prescribed dosage schedules is essential for optimal results.

Safe Storage and Handling

To maintain the stability and efficacy of Ritonavir Tablets IP, store the medication below 30C in a tightly closed container, protected from moisture. Always check the packaging for batch number, expiry, and MRP information, and keep the tablets out of reach of children. Dispose of unused medication safely as directed by a healthcare provider.

FAQ's of Ritonavir Tablets IP:

Q: How should Ritonavir Tablets IP 100 mg be taken for HIV-1 infection?

A: Ritonavir Tablets IP 100 mg should be taken orally exactly as prescribed by your physician, usually in combination with other antiretroviral medications. The dosage is determined by the doctor based on your age, body weight, and response to treatment.

Q: What are the primary benefits of using Ritonavir Tablets IP in HIV therapy?

A: Ritonavir acts as a protease inhibitor, which helps decrease the amount of HIV in the body. When used alongside other antiretroviral agents, it boosts their effectiveness, helping to better control HIV infection and improve immune system function.

Q: When and how often should I take my Ritonavir Tablets?

A: The timing and frequency of Ritonavir Tablets administration depend on your physician's specific instructions, which consider your overall health and treatment plan. Never self-adjust the dosage or schedule; always follow your doctor's guidance precisely.

Q: Where should Ritonavir Tablets IP be stored to ensure their effectiveness?

A: Store the tablets below 30C in a dry place, with the bottle tightly closed. Protect them from moisture and keep them in their original packaging until ready for use. Always keep medication out of reach of children.

Q: What precautions should be followed while using Ritonavir Tablets IP?

A: Use Ritonavir only under medical supervision. Do not share your medication with others, and inform your doctor of all medications you are taking to avoid potential drug interactions. Follow all storage and handling instructions on the packaging.

Q: Who are Ritonavir Tablets IP suitable for?

A: Ritonavir Tablets IP are suitable for adults and children over two years old as directed by a healthcare provider, specifically as part of a combination regimen for the treatment of HIV-1 infection.